Please login to the form below

Not currently logged in
Email:
Password:

Epidiolex

This page shows the latest Epidiolex news and features for those working in and with pharma, biotech and healthcare.

US approval for first ever cannabis-based medicine

US approval for first ever cannabis-based medicine

US approval for first ever cannabis-based medicine. UK company's Epidiolex tipped to be blockbuster. ... Once this recategorisation is completed within the next 90 days, GW Pharma will launch Epidiolex in the US.

Latest news

  • The year of the blockbuster The year of the blockbuster

    Epidiolex from GW Pharmaceuticals:With a PDUFA date in June, GW Pharmaceuticals’Epidiolex (plant-derived cannabidiol) has the potential to become the first cannabinoid-based anti-epileptic medication. ... The industry will watch carefully whether

  • GW ascendant as epilepsy drug clears phase III trial GW ascendant as epilepsy drug clears phase III trial

    GW ascendant as epilepsy drug clears phase III trial. Epidiolex proves effective in controlling seizures in children with Dravet syndrome. ... GW has been scaling up its commercial organisation and production capacity in anticipation of commercial demand

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Ali Frederic Ben-Amor
Tackling a formidable foe
Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
Geoff
Cancer care – the power of new technologies
With patient numbers set to soar, how can we make a difference?...
image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...

Infographics